To view this email as a web page, click here.

NPs and PAs in Dermatology
 
COMMENTARY
 
Allergy guideline recommendations and novel immunomodulators
This month we're looking at new allergy guideline recommendations, whether or not 'natural' soap is milder and the impact of novel immunomodulators.
Read Joe Gorelick's takeaways.
 
CLINICAL CONSIDERATIONS
 
Guidelines recommend early peanut introduction
Experts weigh in on what to know about the new addendum to the peanut allergy prevention guidelines.
Find out more.
 
Is 'natural' soap milder
It is unclear what constitutes "natural" soap, since all soap is really natural, however there is a trend toward the purchase of homemade soap.
Learn more.
 
Novel immunomodulators expected to usher in new therapeutic era
A number of systemic and topical treatments for atopic dermatitis are being developed that feature novel mechanisms of action targeting the inflammatory axes involved in the disease.
Learn more.
 
In case you missed it
 
Brodalumab approved for psoriasis
Research gaps persist in psoriasis, psoriatic arthritis
Emerging cosmeceuticals
 
DIGITAL EDITION
 
March features
Wound healing technologies, updated rosacea guidelines, nasal reconstruction and more are all inside this month's issue of Dermatology Times.
Catch up on today's trends
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.